A Study of IMC-A12 in Advanced Solid Tumors

NCT01007032 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Tumors

Interventions

BIOLOGICAL: Cixutumumab

Sponsor

Eli Lilly and Company

Collaborators

[object Object]
[object Object]